Bio Preventive Medicine Corp. Ltd. of Zhubei City, Hsinchu at MEDICA 2020 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

Bio Preventive Medicine Corp. Ltd.

6f-1, No. 18 Taiyuan St., 30265 Zhubei City, Hsinchu
Taiwan
Telephone +886 3 5601816
Fax +886 3 5601916
info@bpmbiotech.com

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

Contact

Howie Yiu

Business Development

Taiwan

Phone
+886 3 5601816 ext.130

Email
howie.yiu@bpmbiotech.com

Our range of products

Product categories

  • 03  Diagnostic tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.01  Immuno assay testing

Our products

Product category: Immuno assay testing

DNlite-IVD103: novel diagnostic solution for precision DKD management

BPM’s expertise in Diabetic Kidney Disease (DKD) and non-proteinuric renal disease led to the development of first breakthrough IVD product, DNlite-IVD103, which detecting a post translational modification of a DKD biomarker and identified by large urinary proteomic studies (+3,000 patients). DNlite-IVD103 is a non-invasive urinary ELISA test for predicting/ monitoring the progression of DKD, and has obtained CE IVD mark, Malaysia MDA and other regulatory-approvals for global market.

DNlite-IVD103: 
  • Non-invasive urine ELISA test: perfect for clinical practice
  • Predict &  monitor progressive decliner of DKD months to years earlier
  • Risk assessment for kidney function loss
  • Precision DKD management & complementary test
  • Proven quality (CE IVD marked & ISO13485/ GMP)

More Less

About us

Company details

Bio Preventive Medicine (BPM) is a leading company in renal biomarker area. As an innovative and clinical staged biotech company, BPM has focus on translating validated and IP-protected biomarkers into diagnostic solutions for unmet clinical needs, especially among the fields of disease’s early detection and prevention in diabetes related complications, such as CKD and CVD, kidney injury, and oncology (upper GI cancer).

To advance precision medicine and reduce healthcare burden globally in chronic diseases and oncology, BPM develops clinically proven biomarkers and high value-added diagnostic products, that enable unprecedented efficiencies in the development of therapies. BPM constantly contribute its expertise and is seeking to partner and collaborate with leading industry organizations.

For more information, please visit: https://www.bpmbiotech.com/

More Less

Company data

Area of business

Diagnostics